Hos patienter med ankyloserende spondylitis, som fik Enbrel, var den kliniske respons synlig på tidspunktet for første besøg (2 uger) og blev opretholdt gennem 6 måneders behandling.
Among patients with ankylosing spondylitis who received Enbrel, the clinical responses were apparent at the time of the first visit (2 weeks) and were maintained through 6 months of therapy.